Showing 313–319 of 319 results

Xpreza 200 mg Tablet

Molecule : AzacitidineManufacturer : Natco Pharma
Ask for Price

Xtandi 40 mg Tablet

Molecule : EnzalutamideManufacturer : Astellas Pharma
Ask for Price

Xtandi 80 mg Tablet

Molecule : EnzalutamideManufacturer : Astellas Pharma
Ask for Price

Yervoi 50 mg Injection

Molecule : IpilimumabManufacturer : Bristol Myers Squibb
Ask for Price

Zelboraf Vemurafenib 240 mg Tablet

Molecule : VemurafenibManufacturer : Roche
Ask for Price

Zydelig Idelalisib 100 mg Tablet

Molecule : IdelalisibManufacturer : Gilead
Ask for Price

Zydelig Idelalisib 150 mg Tablet

Molecule : IdelalisibManufacturer : Gilead
Ask for Price

Related Posts:

PARP Inhibitors Explained: Olaparib, Niraparib, Rucaparib, and Talazoparib

If you have been diagnosed with ovarian, breast, prostate, or pancreatic cancer, or if your close relative faces a similar

READ MORE »
CDK4/6 Inhibitors for Breast Cancer: Palbociclib vs. Ribociclib vs. Abemaciclib

Treatment strategies for HR-positive, HER2-negative breast cancer have seen an amazing transformation over time. Traditionally, patients with advanced/metastatic disease within

READ MORE »
EU Approves First-Line Targeted Treatment for BRAF-Mutant Advanced Colon Cancer

The EC has now given its green light to encorafenib (Braftovi) when used in combination with cetuximab (Erbitux) and FOLFOX

READ MORE »